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Abstract
Trypanosoma cruzicauses Chagasic heartdisease, a major public
health problem in Latin America. The mechanism ofinteraction
ofthis protozooan parasite with host cells is poorly understood.
We recently found-that the infective trypomastigote form of T.
cruzi exhibits neuraminidase activity and can desialylate mam-
malian erythrocytes. However, it is not known if T. cruzi can
also modify the surfaces ofcardiovascular cells that are directly
involved in the most important clinical manifestations of this
disease.Accordingly, thisstudydetermined whether T.crzican
remove sialic acid from cultured rat myocardial or human vas-
cular endothelial cells. Sialic acid was labeled metabolically with
the precursor 3H-N-acetyl-D-mannosamine. Soluble peuramin-
idase, isolated from intact T. cruzi trypomastigotes, caused sig-
nificant release of labeled material from myocardial cells (e.g.,
2,174±27 dpm/h vs. spontaneous release of 306±30 dpm/h, n
= 4, P < 0.001). Chromatographic analysis showed that the
bulk ofthe radioactivity released by T. cruzineuraminidase was
sialic acid. Intact T. cruzi trypomastigotes also released sialic
acid from metabolically labeled myocardial cells in a concentra-
tion-dependent manner. In contrast, a noninfective form of T.
cruzi, the amastigote, did not desialylate these cells. Galactose
oxidase labeling demonstrated newly desialylated glycoproteins
on the surface of myocardial cells treated with T. cruzi neur-
aminidase. Desialylation ofmyocardial cells was confirmed his-
tochemically by the appearance of binding sites for peanut ag-
glutinin, a lectin that binds to complex oligosaccharide moieties
after removal of the terminal sialyl residue. T. cruz neuramin-
idase also removed sialic acid from adult human saphenous vein
endothelial cells, as determined by both histochemical and met-
abolic labeling studies. Thus, infective forms of T. cruzi can
chemically modify the surfaces of myocardial and vascular en-
dothelial cells by desialylation. This alteration may play a role
in the initial interaction of this parasite with these important
target cells ofthe host cardiovascular system.
Introduction
Chagas' disease is endemic in large areas ofthe southern halfof
the western hemisphere, and affects more than 10 million people
(1). Cardiacabnormalities includingbiventricularfailure, severe
brady- ortachyarryhthmias, and aneurysms ofthe leftventricular
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apex are the most important clinical consequences ofthis disease
(1). Since in the mammalian host Trypanosoma cruzi can only
multiply within cells, the parasite's initial interaction with host
cells must be essential in the pathogenesis of Chagas' disease.
Nogueira and colleagues (2, 3) have examined in detail the in-
teraction of this parasite with the macrophage. Others have
studied the interaction of T cruzi with certain established cell
lines, particularly fibroblasts (4-6). We recently described a
neuraminidase activity associated with the surface of infective
forms of T. cruzi that can remove sialic acid from mammalian
erythrocytes both in vitro and in vivo (7, 8).
'However, none of these previous studies have focused on
the interaction ofT cruzi with the differentiated cardiovascular
cellsthataretheimportant targetsinthepathogenesisofChagasic
heart disease. The surfaces of myocardial and vascular endo-
thelial cells also contain functionally important sialylated mac-
romolecules that are potential substrates for this enzyme. Ac-
cordingly, this studytested whethertheneuraminidase associated
with infective forms of T. cruzi could modify by desialylation
the surfaces ofintact, functioning mammalian myocardial and
vascular endothelial cells in' primary culture. Because of the
multiple important biological functions of surface sialoglyco-
proteins and the many consequences of desialylation, such
modification might play a role in the interaction ofthis parasite
with these clinically important host cells.
Methods
Sources and preparations of T. cruzi. T. cruzi trypomastigotes of two
different strains (Y and Montalvania) were propagated in cultured bovine
aortic smooth muscle cells, prepared as described previously (9).'3-5 d
after initial infection, amastigote forms were harvested from the culture
supernatants. Trypomastigote forms were harvested from similar cultures
infected for 7-10 d, and were purified on a metrizamide gradient (7).
After harvesting the parasites were washed three times' in phosphate-
buffered saline (PBS; NaCl, 150 mM; NaPO4, 10 mM; pH 7.2) and
counted in a hemocytometer.
Preparation andassayofT. cruzineuraminidase. Acrudepreparation
ofsoluble T. cruzi neuraminidase was made by incubating trypomasti-
gotes with Dulbecco's modified Eagle's medium (DME)' or RPMI 1640
medium at 4VC for 48-72 h. Tld neuraminidase activity in this and
other materials was measured by the hemagglutination ofrabbit eryth-
rocytes using peanut agglutinin as described previously (7, 8). 1 U of
neuraminidase is defined as the amount of enzyme that hydrolyzes 1
4mol ofN-acetyl-neuraminic acid from hiiuman acidalpha,-glycoprotein
per minute at 370C (8).
We detected no difference in the substrate specificities ofthe neur-
aminidase produced by these two strains (data not shown). However,
preparations from the Montalvania strain generally had higher titers of
neuraminidase activity than those from the more widely studied Y strain.
Ingeneral, 106trypomastigotes oftheY strainyielded '-7 sU ofactivity,
1. Abbreviation used in this paper: DME, Dulbecco's modified Eagle's
medium.
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This study used both parasites ofboth strains in order to test whether
anybiological effects ofthis enzyme activity might be limited to a strain
that produced this enzyme in high amounts.
Preparation ofneonatalrat heart cellcultures. Myocardial cells were
prepared bytrypsin dissociation ofheartsof1-2-d-old ratpups, enriched
forcardiac myocytes bydifferential adhesion, and plated at 2 X 105/cm2
(10). Toretardtheproliferation ofnonmyogeniccellsfurther, themedium
was changed to DME containing fetal calf serum (10%) and cytosine
arabinoside (10-s M) the day after initial plating. After 3 d ofincubation
in this medium, the cultures consisted mostly ofcontractile cells with
the characteristic phase microscopic appearance of cardiac myocytes.
Cells were generally used for experiments within I wk ofpreparation.
Preparation ofhumansaphenous veinendothelialcellcultures. These
cells were prepared from unused portions of saphenous vein obtained
during coronary artery bypass surgery. This use ofnormally discarded
tissue was approved by the Human Investigation Review Committee of
the New England Medical Center, Boston, MA. Endothelial cells har-
vested by treatment with collagenase (0.1% Worthington type II; Wor-
thington [Cooper Biomedical, Inc.] Malvern, PA) were plated on tissue
culture ware coatedwith human fibronectin (1.5 ,gg/cm2) and maintained
in Medium 199 buffered with Hepesand supplemented with endothelial
cell growth factor (50 ,gg/ml) and porcine heparin (100 ,g/ml). These
cells exhibited characteristic morphology, stained for von Willebrand
factor in a rodlike or punctate distribution as determined by immuno-
fluorescence or immunohistochemistry, and contained von Willebrand
factor mRNA (data not shown). These cells were used for experiments
in their third to fourth passage.
Metabolic labeling ofsialic acid. To measure release of sialic acid
from the myocardial cell surface, we used theability ofthe cultured cells
to incorporate isotopically labeled precursors ofsialic acid into macro-
molecular glycoconjugates (11, 12). Intact cells labeled in this manner
wouldbe suitable substrates fordetermining neuraminidase activity. We
usedN-acetyl-D-mannosamine (6-3H, 10 mCi/mmol, New England Nu-
clear, Boston, MA) and D-mannosine (1-14C, 45 mCi/mmol, Research
Products International Corp., Mt. Prospect, IL) as precursors. Initial
experiments showed that incorportion oftritiated N-acetyl-D-mannos-
amine (5 ACi/ml) into material insoluble in perchloric acid (0.2 M) was
linear for up to -40 h and then tended to reach a plateau (data not
shown). After a48-h incubation with tritiatedN-acetyl-D-mannosamine
under these conditions, followed by four 1-h washing periods in fresh
medium without radioactive precursor, <20% of the radioactivity as-
sociatedwiththecelllayerwasintheform ofmaterialsolubleinperchloric
acid (0.2 M). Thus, this procedure primarily labeled macromolecules.
Incubation ofcells labeled in this manner with purified neuraminidase
from Vibriocholera (5 MU/ml;Gibco, Grand Island, NY) released 19±3%
ofthe radioactivity associated with the cell layer (n = 5). These results
indicate that at least afifth ofthe labeled macromolecules were accessible
to an exogenous hydrolase.
Although N-acetyl-D-mannosamine isadirect and relatively specific
precursor of sialic acid, transport of this acetylated sugar may be less
efficient than transport ofthe less direct precursor D-mannosamine (11,
12). Therefore, we simultaneously compared labeling characteristics in
dual isotope experiments with tritiated N-acetyl-D-mannosamine and
'4C-labeled mannosamine. Rat myocardial cells were incubated in the
presence ofthe tritiated precursor (1 ACi/ml) and '4C-D-mannosamine
(0.5 ACi/ml) for 65 h. After four 1-h washes with fresh medium, the
monolayerswere fractionated into material soluble and insoluble in per-
chloric acid (0.2 M). While cultured myocardial cells took up much
more radioactivity from the unacetylated sugar, the proportion ofman-
nosamine incorporated into macromolecules was much less than in the
case ofN-acetyl-D-mannosamine (data not shown). Although N-acetyl-
D-mannosamine didprovetobeamorespecific label formacromolecules,
experiments were often performed using both precursors simultaneously.
While wegenerally present results with N-acetyl-D-mannosamine, similar
results were always obtained with the unacetylated mannosamine.
In some experiments, cellular proteins were labeled by incubation
with '4C-tyrosine (uniformly labeled 460 mCi/mM, 0.2 MCi/ml). After
the cell layers were washed asdescribed above, -94% oftheradioactivity
was insoluble in perchloric acid (0.2 M).
Chromatographicanalysisofsialicacid. Todeterminethedistribution
of radioactivity released from metabolically labeled cardiac cells, the
supernatantswereanalyzedbychromatography(13, 14). Material released
from metabolically labeled cells was Iyophilized, applied to columns (1
by 3 cm) of Dowex 2X-8 (in the formate form) and washed with water
(10 column volumes). This effluent contained <15% ofthe total radio-
activity. The anionic material bound to the column was eluted with
formic acid (2 M, 10 column volumes). Total recovery ofradioactivity
from thisionexchangecolumn was>89%. Theacideluatewasevaporated
to dryness, dissolved in sulfuric acid (6 N, 0.2 ml), and analyzedbyhigh
performance liquid chromatography on an Aminex HPX-87H organic
acid column (Bio-Rad Laboratories, Richmond, CA) that was eluted
isocratically with sulfuric acid (3 mM) at 0.7 ml/min. Fractions were
analyzed for radioactivity by liquid scintillation spectrometry. The col-
umn was standardized with D-mannose, N-acetyl-D-mannosamine,
N-acety!-neuraminic acid, and N-glycolyl-neuraminic acid.
Galactose oxidase labelingofmyocardial cells. Externally disposed,
terminal galactosyl residues were labeled by thegalactose oxidase method
(15). To reduce any existing free aldehyde functions on the cell surface,
monolayers were first exposed to sodium borohydride (1 mM) in a buff-
ered salt solution that lacked glucose(NaCI, 116 mM, Hepes, 16.5 mM,
NaHCO3, 10 mM, KCI, 5.4 mM, CaCl2, 1.8 mM, NaH2PO4, 1.0 mM,
and MgSO4, 0.8 mM). After washing, the cell layers were incubated
under various conditions, then treated with galactose oxidase (I mg/ml,
Worthington (Cooper Biomedical, Inc.) for 1 h. After washing, the
monolayers were exposed to sodium borotritiide (0.1 mCi/ml) for 10
min at room temperature in the glucose-free buffer described above.
After four washes in this buffer, the cell layer was dissolved in twofold
concentrated Laemmli sample solvent(16). This extract wasimmediately
boiled for 10 min (to inactivate susceptible proteases) and then stored
frozen. Portions ofthisdigest were analyzedby polyacrylamidegel elec-
trophoresis onlinear 5-15%gradientsusingadiscontinuousbuffersystem.
After staining with Coomassie Blue, the gels were treated with Enhance
(New England Nuclear) according to the manufacturer's instructions,
dried, and exposed to X-omat AR-5 film at -70°C with a Cronex in-
tensifying screen (Dupont Instruments, Wilmington, DE).
Histochemical visualization ofpeanut agglutinin bindingsites. Tissue
culture cells were fixed with buffered formalin (10%). Endogenous per-
oxidase activity was blocked by incubating the cells in H202 (2%). The
fixed cell layer was covered with a filtered liver powder solution at a
concentration of 100 ,ug/ml in PBS for 10 min and then washed with
PBS. The cells were then incubated for 30 min at room temperature
with biotinylated peanut agglutinin (20 Ag/ml), washed three times for
5 min with PBS, andthen incubated with avidin-biotin-peroxidase com-
plex as described previously (17). Horseradish peroxidase was visualized
by incubation with PBS containing 3,3'diaminobenzidine tetrahydroch-
loride and H202. The slides were then washed in tap water for 5 min,
counterstained with methyl green, dehydrated, and coverslips were at-
tached with permount. Positive staining was demonstrated by the dark
diaminobenzidine-H202 reaction product.
Results
T. cruzi neuraminidase releases sialic acidfrom metabolically
labeled myocardial cells. Soluble neuraminidase shed by intact
T. cruzitrypomastigotes released radioactivity originating from
both tritiated N-acetyl-D-mannosamine and 14C-mannosamine
at an approximately constant rate for I h at 37°C (Fig. 1). Sub-
sequent experiments therefore generally measured release ofra-
dioactivity during the first hour when the rate reflected the ap-
parent initial velocity of the reaction. Spontaneous release of
radioactivity was always measured simultaneously in enzyme-
free blank conditions, and averaged 13±1.3% ofthe release in-
duced by V. cholera neuraminidase (5 gU/ml, Gibco;
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Figure 1. Time course ofsialic acid release from myocardial cells by
T. cruzi neuraminidase. Rat heart cells were labeled with 3H-N-acetyl-
D-mannosamine, 5 ACi/ml, and '4C-D-mannosamine, 0.1 Ci/ml, on
Costar 12 plates. T. cruzi neuraminidase was prepared in DME sup-
plemented with insulin (10'). The values reported are the difference
ofthe spontaneous release at the same time point from the release in
wells incubated with T. cruzi neuraminidase (mean±SE of2-4 wells).
The release oftritium counts is shown in open circles (ManNAc); re-
lease of 14C is shown in closed circles (ManNH2).
mean±SEM ofaverage values from seven independent experi-
ments each performed on 4-6 replicate wells). In preliminary
experiments under these conditions, this concentration of the
bacterial neuraminidase was maximally effective (data not
shown).
In each of seven independent experiments, soluble neur-
aminidase from T. cruzi(either Y or Montalvania strains)caused
net release ofradioactivity. The activity ofindividual prepara-
tions ofT cruzi neuraminidase depends on such factors astime
ofstorage and strain oforigin. Accordingly, theamount ofsialic
acid release varied in individual experiments. In fiveexperiments,
the release induced by T. cruzi conditioned medium was mea-
sured in parallel with that produced by V cholera neuraminidase
(5 gU/ml). In theseexperiments, T. cruzineuraminidase released
from 10 to 113% (mean 67%) ofthe radioactivity released by
this constant amount of V. cholera enzyme.
Characterization ofthe radioactive products released by T.
cruzineuraminidasefrom metabolicallylabeledmyocardialcells.
The releaseofradioactivity from metabolically labeled cellsmight
conceivably be due to proteolytic activity elaborated by T. cruzi
or that may contaminate the V. cholera neuraminidase. To test
this possibility, we measured simultaneously the release of ra-
dioactivity from myocardial cells labeled with both tritiated N-
acetyl-D-mannosamine (to label sialic acid) and "4C-tyrosine (to
label protein). Neuraminidase from either T. cruzior V. cholera
increased release of radioactivity originating from tritiated N-
acetyl-D-mannosamine greater than sixfold, but did not release
'4C-radioactivity from labeled proteins (Table I). In contrast,
treatment with the proteolytic enzyme trypsin (5 ug/ml) in-
creased the release ofradioactivity associated with both the pro-
tein and the sugar label to the same extent. This result indicates
that while trypsin cleaves glycopeptides containing both amino
acids and carbohydrate residues from externally disposed gly-
coproteins, the neuraminidase activity released by T. cruzi se-
lectively releases carbohydrate moieties.
To define further the chemical identity of the radioactive
material(s) released by neuraminidase from myocardial cell sur-
faces labeled with N-acetyl-D-mannosamine, we analyzed these
Table I. Susceptibility to Hydrolysis by Neuraminidase or
Trypsin ofSialicAcidandProteinsfrom the
Surface ofMetabolically LabeledRat Myocardial Cells
Sialic acid released* Protein released*
(3-H dpm) (14-Cdpm)
Control 306±30 381±44
T. cruzi neuraminidaset
(10 uU/ml) 2,174+27 463±22
V. cholera neuraminidase
(10UU/ml) 1,963+210 419±16
Trypsin (5 Ag/ml) 1,165±82 1,133±101
* Metabolic labeling ofsialic acid with tritiated N-acetyl-D-mannos-
amine and ofcell protein with U-'4C-tyrosine was performed as de-
scribed in Methods.
t T. cruzi neuraminidase was isolated from trypomastigotes ofthe Y
strain as described in Methods.
products chromatographically. The anion exchange resin Dowex
2X-8 bound 93% ofthe radioactivity released by T. cruzi neur-
aminidase. The radioactive material eluted by formic acid (2
M) from this Dowex column co-migrated with authentic N-ace-
tyl-neuraminic acid on an organic acid high performance liquid
chromatography column (Aminex HPX-87H) (Fig. 2). These
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Figure 2. High performance liquid chromatography ofmaterial re-
leased from rat heart cells metabolically labeled with tritiated-N-acetyl-
mannosamine. Neonatal rat myocardial cell cultures were labeled with
tritiated N-acetyl-D-mannosamine, washed, and incubated with T.
cruzi neuraminidase or V. cholera neuraminidase (5 U/ml for 1 h) as
described in the Methods section. Greater than 85% ofthe radioactiv-
ity released into the medium bound to Dowex 2X-8 at neutral pH.
The material eluted from the Dowex columns by formic acid (2 M)
was applied to an Aminex HPX-87H high performance liquid chro-
matography column eluted as described in the Methods section. The
recovery ofthe radioactivity from this column was 89% in the case of
T. cruzi neuraminidase. The arrows show the positions where authen-
tic standard sugars eluted during calibration runs under identical con-
ditions. NANA, N-acetyl-neuraminic acid, GlcNAc, N-acetyl-D-glucos-
amine; Fuc, L-fucose; and ManNAc, N-acetyl-D-mannosamine. The
radioactivity released by either T. cruzi neuraminidase (close circles)
or purified neuraminidase from V cholera (open circles) eluted as sin-
gle peaks in the same position as authentic sialic acid (NANA). Simi-
lar results were obtained in an independent experiment.
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species released by T. cruzi neuraminidase from myocardial cells
metabolically labeled with N-acetyl-D-mannosamine.
Intact living T. cruzi trypomastigotes releasesialicacidfrom
myocardial cells. The foregoing experiments indicated that
neuraminidase shed by T. cruzi can remove sialic acid from the
myocardial cell surface. It was also important to determine if
the intact parasite could desialylate myocardial cells. Live T.
cruzi trypomastigotes released metabolically labeled sialic acid
from rat heart cells in three independent experiments with the
Ystrain. In arepresentative experiment, netrelease ofsialicacid
with 5 X 108 cells/ml was 1,268±362 dpm/h. Incubation ofrat
heart cells with trypomastigotes ofthe myotropic Montalvania
strain also induced release ofsialic acid in a concentration de-
pendent manner (Fig. 3). These results demonstrate that intact,
living T. cruzi can release sialic acid from the surface ofbeating
rat myocardial cells.
Noninfective amastigoteforms ofT. cruzifail to release sialic
acidfrom myocardial cells. Neuraminidase production by T.
cruzi depends on the developmental stage ofthe organism. The
infective trypomastigote form expresses a high titer ofactivity
while noninfective epimastigotes, found in the insect vectorand
under some conditions in vitro, express much smaller amounts
ofthis activity (7). Amastigotes, the intracellular replicative form
of T. cruzi, neither infect cells nor produce neuraminidase. We
isolated amastigotes and trypomastigotes from bovine aortic
smooth muscle cells infected simultaneously with the Montal-
vania strain of T. cruzi. We then exposed metabolically labeled
rat myocardial cells to optimum concentrations of either live
trypomastigotes or an equal number ofamastigotes (108 organ-
isms/ml). The amastigotes did not release sialic acid, while T.
cruzi trypomastigotes or purified V. cholera neuraminidase did
remove sialic acid from the myocardial cells under identical
conditions (Fig. 4).
Specific myocardial cellsurfaceglycoprotein substrates ofT.
cruzi neuraminidase. The above experiments demonstrated re-
lease ofsialic acid from externally disposed glycoconjugates on
the myocardial cell surface. To characterize furtherthe substrates
for T. cruzi neuraminidase, we used galactose oxidase labeling,
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Figure 4. Comparison ofneuraminidase activity in T. cruzi trypomas-
tiges and amastigotes. Rat heart cells labeled with 3H-N-acetyl-D-man-
nosamine were incubated with amastigotes ortrypomastigotes ofthe
Montalvania strain (108 cells/ml) prepared in parallel. The data re-
ported are mean±SE of4-6 observations. The numbers above the
bars indicate the percentage ofthe total radioactivity that was released
during I h. The control condition was tissue culture medium without par-
asite cells. The purified neuraminidase was from V cholera (5 MU/ml).
a technique that specifically demonstrates newly desialylated
glycoproteins (16). Myocardial cell cultures were first treated
with sodium borohydride to reduce all accessible free aldehyde
groups. When neuraminidase removes aterminal sialicacid res-
idue from an N- or O-linked complex oligosaccharide chain of
a glycoprotein, it uncovers a galactose or N-acetyl-D-galactos-
amine residue. An hydroxyl group ofthe newly exposed sugar
can then be oxidized to thecorresponding aldehyde by treatment
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Figure 3. Concentration dependence ofsialic acid release from myo-
cardial cells by T. cruzi trypomastigotes. Rat heart cells labeled with
3H-N-acetyl-D-mannosamine were incubated with live T. cruzi trypo-
mastigotes ofthe Montalvania strain for I h. Data reported are
mean±SE ofthe mean ofacid-insoluble radioactivity released from 4
to 6 cultures in each condition.
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Figure 5. T cruzi neuraminidase desialylates myocardial cell glycopro-
teins demonstrated by galactose oxidase labeling. Myocardial cell cul-
tures were incubated in medium with or without T. cruzi neuramini-
dase or V. cholera neuraminidase (10 MU/ml) for I h before galactose
oxidase surface labeling. Extracts ofthe labeled cell layers were elec-
trophoresed on a polyacrylamide gradient gel (5-15%). A photograph
ofthe Coomassie Blue stained gel shows that equal amounts ofpro-
tein were applied to each lane (A). The fluorograph ofthe same gel is
shown in B. In each panel, the conditions were (from left to right): (1)
control, treated with neither neuraminidase nor galactose oxidase; (2)
control, not treated with neuraminidase but incubated with galactose
oxidase; (3) culture incubated with T. cruzi neuraminidase and then
galactose oxidase; and (4) culture treated with V. cholera neuramini-
dase and then galactose oxidase. An independent experiment showed
similar results. kdal, kilodalton.
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9 A..with theenzyme galactose oxidase. This newly formed aldehyde
group is then reduced by treatment with sodium borotritiide,
which introduces two tritium atoms into each desialylated po-
sition in the oligosaccharide chain. Extracts ofcultures labeled
in this manner after neuraminidase treatment were analyzed by
electrophoresis (Fig. 5). Each lane of this gel contained equal
amounts ofprotein stainable by Coomassie Blue (Fig. 5 A). Cell
cultures that had not been treated with neuraminidase showed
no tritiated protein bands (Fig. 5 B). However, cultures treated
with neuraminidase from either T. cruzi or V. cholera showed
labeled protein bands in a similar pattern (Fig. 5 B, righthand
lanes). One of these bands had an apparent molecular weight
>200,000. Thiselectrophoretic behavior is similar to that ofthe
well-known cell surface glycoprotein fibronectin.
Histochemical evidencefor desialylation ofmyocardial cell
surface molecules. To verify the results obtained with metabolic
labeling and galactose oxidase labeling experiments we used an
independent technique. Galactose residues uncovered by desi-
alylation ofoligosaccharide chains will bind peanut agglutinin
(17). The appearance ofbinding sites for this galactose-binding
lectin was visualized by an avidin-biotin immunoperoxidase
linked technique. Cultures of rat myocardial cells not treated
with neuraminidase showed no binding of peanut agglutinin.
However, after incubation with neuraminidase from either T.
cruzi or V. cholera, myocardial cell cultures showed abundant
binding ofthis lectin (Fig. 6).
T cruzi neuraminidase also releases sialic acidfrom adult
human vascular endothelial cells. Blood-borne trypomastigotes
in the mammalian host must cross the endothelial barrier to
invade peripheral tissues such as myocardium. In addition, de-
sialylation ofendothelium can increase platelet adhesion to ar-
teries (18). Therefore, we determined whether T. cruzi neur-
aminidase could also remove sialic acid from vascularendothelial
cells. Neuraminidase from T. cruzi did release metabolically la-
beled sialic acid from adult human saphenous vein endothelial
cells(Fig. 7), as well as from bovine aortic endothelial cells (data
not shown). This result was confirmed by histochemical studies
that showed binding ofpeanut lectin to neuraminidase-treated
but not to control cultures of adult human endothelial cells
(Fig. 8).
Discussion
Death due toChagas' disease isusually caused bychronic cardiac
involvement (1). The etiologic agent ofthis disease, T. cruzi, is
an obligate intracellular parasite. During the acute phase of
Chagas' disease the parasites enter and multiply within myo-
cardial cells, and their progeny must exit from these cells in
order to propagate the infection. Before encountering the myo-
cardial and other potential target cells, the blood-borne trypo-
mastigote must traverse the vascular endothelium. For the par-
asite to enter or exit myocardial or endothelial cells, it must
contact two structures rich in functionally important sialylated
glycoproteins: the basement membrane or glycocalyx, and the
plasmalemma itself(19-22).
Sialoglycoconjugates ofthe cell surface play many important
roles in physiology and pathology (23). In some preparations of
cardiac tissue, negatively charged sialic acid residues appear to
modulate the access ofcalcium ions to the sarcolemma (19, 22,
24-26). Desialylation ofmammalian cells can also activate the
alternative pathway ofcomplement (27).
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Figure 7. T. cruzi neuraminidase releases sialic acid from human vas-
cular endothelial cells. Human saphenous vein endothelial cell cul-
tures labeled with 3H-N-acetyl-D-mannosamine were incubated for I h
with neuraminidase shed by T. cruzi (Montalvania strain, 7 MU/ml) or
from V. cholera (10 MU/ml). The bars show release ofsialic acid in the
medium (n = 4, mean±SEM). The numbers above the bars indicate
the percentage ofthe total radioactivity released during the hour incu-
bation. The control condition was tissue culture medium without par-
asite cells. An independent experiment gave similar results.
Sialyl residues on the lumenal surface of vascular endothe-
lium can also influence the interactions ofblood cells with the
vessel wall in important ways (28). Forexample, treatment with
neuraminidase promotes the adhesiveness ofplatelets (18) and
granulocytes (29) to endothelium. Desialylation ofthe endothe-
lial surface could contribute to the platelet aggregation and
thrombosis within coronary arteries that accompany cardiac fi-
brosis in mice infected experimentally with T. cruzi (30, 31). In
addition, sialyl residues may account for the selective adhesion
ofcirculating lymphocytes tospecialized venularendothelial cells
in peripheral lymph nodes (32).
We previously demonstrated that during infection of mice
with T. cruzi, desialylation of erythrocytes occurs in vivo in
relation tothedegree ofparasitemia (7). Desialylatederythrocytes
are liable to sequestration perhaps via the asialoglycoprotein
pathway, and are subject to lysis by the alternative pathway of
complement (27, 33). Therefore, this action of T. cruzi neur-
aminidase probably explains the anemia associated with acute
T. cruzi parasitemia (34). However, alteration by T. cruzi ofthe
surfaces ofmyocardial and endothelial cells could be more rel-
evant to development ofthe laterand often lethal chronic phase
ofChagas' disease.
For this reason, it was of interest to determine whether the
activity ofthis enzyme ofparasite origin was limited to eryth-
rocytes, or if it could also hydrolyze sialylated glycoconjugates
present on the surfaces ofthese pathologically important target
cells. By a variety ofindependentcriteria, we foundthat T. cruzi
can indeed desialylate the surfaces ofboth ofthese cardiovascular
cell types in vitro. Soluble neuraminidase shed by infective T.
cruzi trypomastigotes removed sialic acid from these cells as
shown by release of free sialic acid, lectin binding, and cyto-
chemistry.
More importantly, living T. cruzi trypomastigotes also re-
leased sialic acid from intact beating myocardial cells. This de-
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j,sialylation was selective, since the noninvasive, noninfectious
amastigote form ofthis parasite which lacks netraminidase ac-
tivity did not free sialic acid from the host cells. Only the de-
velopmental form of T. cruzi that can infect the mammalian
host cell caused desialylation. This result is consistent with in-
volvement ofthe parasite neuraminidase in the initial host-try-
panosome interaction atthecellular level. A precedent forarole
for neuraminidase activity in the pathogenesis ofan intracellular
infection is found in myxovirus. Neuraminidase on the surface
ofinfluenza virus is not only an immunogen, but can influence
tissue tropism and aid the viral particle to enter orleave the host
cell as well (35, 36).
This study demonstrated a novel biochemical change in the
surface of cardiovascular cells produced by infective forms of
T. cruzi. The precise role that T. cruzi neuraminidase might
play in the pathophysiology ofChagas' disease is not yet clear.
However, the results presented here are consistent with a role
for this enzyme in the critical early interaction ofthis parasite
with important mammalian target cells. This initial interaction
ofhost and parasite cells is a necessary precursor to development
ofthe late cardiac disease. The chemical alteration ofthe host
cell surface by the parasite that was demonstrated here should
stimulate future work to delineate the potential role of T. cruzi
neuraminidase activity in the variety ofmechanisms implicated
in the production ofChagasic cardiovascular disease (37-39).
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